201 related articles for article (PubMed ID: 34979351)
1. The questionnaire design process in the European Human Biomonitoring Initiative (HBM4EU).
González-Alzaga B; Hernández AF; Kim Pack L; Iavicoli I; Tolonen H; Santonen T; Vinceti M; Filippini T; Moshammer H; Probst-Hensch N; Kolossa-Gehring M; Lacasaña M
Environ Int; 2022 Feb; 160():107071. PubMed ID: 34979351
[TBL] [Abstract][Full Text] [Related]
2. HBM4EU feasibility studies: Lessons learned in combining health and human biomonitoring studies.
Elonheimo HM; Uusitalo K; Moore S; Andersson AM; Baber R; Wirkner K; David M; Kolossa-Gehring M; Stewart L; Sepai O; Lermen D; Bartel-Steinbach M; Rantakokko P; Koponen J; Tolonen H
Int J Hyg Environ Health; 2023 Mar; 248():114100. PubMed ID: 36508963
[TBL] [Abstract][Full Text] [Related]
3. Application of human biomonitoring data to support policy development, raise awareness and environmental public health protection among countries within the HBM4EU project.
Ubong D; Stewart L; Sepai O; Knudsen LE; Berman T; Reynders H; Van Campenhout K; Katsonouri A; Van Nieuwenhuyse A; Ingelido AM; Castaño A; Pedraza-Díaz S; Eiríksdóttir ÁV; Thomsen C; Hartmann C; Gjorgjev D; De Felip E; Tolonen H; Santonen T; Klanova J; Norström K; Kononenko L; Silva MJ; Uhl M; Kolossa-Gehring M; Apel P; Jõemaa M; Jajcaj M; Estokova M; Luijten M; Lebret E; von Goetz N; Holcer NJ; Probst-Hensch N; Cavaleiro R; Barouki R; Tarroja E; Balčienė RM; Strumylaite L; Latvala S; Namorado S; Szigeti T; Ingi Halldorsson T; Olafsdottir K; Wasowicz W;
Int J Hyg Environ Health; 2023 Jun; 251():114170. PubMed ID: 37207539
[TBL] [Abstract][Full Text] [Related]
4. Harmonization of Human Biomonitoring Studies in Europe: Characteristics of the HBM4EU-Aligned Studies Participants.
Gilles L; Govarts E; Rodriguez Martin L; Andersson AM; Appenzeller BMR; Barbone F; Castaño A; Coertjens D; Den Hond E; Dzhedzheia V; Eržen I; López ME; Fábelová L; Fillol C; Franken C; Frederiksen H; Gabriel C; Haug LS; Horvat M; Halldórsson TI; Janasik B; Holcer NJ; Kakucs R; Karakitsios S; Katsonouri A; Klánová J; Kold-Jensen T; Kolossa-Gehring M; Konstantinou C; Koponen J; Lignell S; Lindroos AK; Makris KC; Mazej D; Morrens B; Murínová ĽP; Namorado S; Pedraza-Diaz S; Peisker J; Probst-Hensch N; Rambaud L; Rosolen V; Rucic E; Rüther M; Sarigiannis D; Tratnik JS; Standaert A; Stewart L; Szigeti T; Thomsen C; Tolonen H; Eiríksdóttir Á; Van Nieuwenhuyse A; Verheyen VJ; Vlaanderen J; Vogel N; Wasowicz W; Weber T; Zock JP; Sepai O; Schoeters G
Int J Environ Res Public Health; 2022 Jun; 19(11):. PubMed ID: 35682369
[TBL] [Abstract][Full Text] [Related]
5. Human biomonitoring initiative (HBM4EU) - Strategy to derive human biomonitoring guidance values (HBM-GVs) for health risk assessment.
Apel P; Rousselle C; Lange R; Sissoko F; Kolossa-Gehring M; Ougier E
Int J Hyg Environ Health; 2020 Sep; 230():113622. PubMed ID: 33045523
[TBL] [Abstract][Full Text] [Related]
6. Phthalates and substitute plasticizers: Main achievements from the European human biomonitoring initiative HBM4EU.
Gerofke A; Lange R; Vogel N; Schmidt P; Weber T; David M; Frederiksen H; Baken K; Govarts E; Gilles L; Martin LR; Martinsone Ž; Santonen T; Schoeters G; Scheringer M; Domínguez-Romero E; López ME; Calvo AC; Koch HM; Apel P; Kolossa-Gehring M
Int J Hyg Environ Health; 2024 Jun; 259():114378. PubMed ID: 38631089
[TBL] [Abstract][Full Text] [Related]
7. Human biomonitoring in health risk assessment in Europe: Current practices and recommendations for the future.
Louro H; Heinälä M; Bessems J; Buekers J; Vermeire T; Woutersen M; van Engelen J; Borges T; Rousselle C; Ougier E; Alvito P; Martins C; Assunção R; Silva MJ; Pronk A; Schaddelee-Scholten B; Del Carmen Gonzalez M; de Alba M; Castaño A; Viegas S; Humar-Juric T; Kononenko L; Lampen A; Vinggaard AM; Schoeters G; Kolossa-Gehring M; Santonen T
Int J Hyg Environ Health; 2019 Jun; 222(5):727-737. PubMed ID: 31176761
[TBL] [Abstract][Full Text] [Related]
8. Implementation of effect biomarkers in human biomonitoring studies: A systematic approach synergizing toxicological and epidemiological knowledge.
Rodríguez-Carrillo A; Mustieles V; Salamanca-Fernández E; Olivas-Martínez A; Suárez B; Bajard L; Baken K; Blaha L; Bonefeld-Jørgensen EC; Couderq S; D'Cruz SC; Fini JB; Govarts E; Gundacker C; Hernández AF; Lacasaña M; Laguzzi F; Linderman B; Long M; Louro H; Neophytou C; Oberemn A; Remy S; Rosenmai AK; Saber AT; Schoeters G; Silva MJ; Smagulova F; Uhl M; Vinggaard AM; Vogel U; Wielsøe M; Olea N; Fernández MF
Int J Hyg Environ Health; 2023 Apr; 249():114140. PubMed ID: 36841007
[TBL] [Abstract][Full Text] [Related]
9. Mixture risk assessment and human biomonitoring: Lessons learnt from HBM4EU.
Luijten M; Vlaanderen J; Kortenkamp A; Antignac JP; Barouki R; Bil W; van den Brand A; den Braver-Sewradj S; van Klaveren J; Mengelers M; Ottenbros I; Rantakokko P; Kolossa-Gehring M; Lebret E
Int J Hyg Environ Health; 2023 Apr; 249():114135. PubMed ID: 36758443
[TBL] [Abstract][Full Text] [Related]
10. Human biomonitoring initiative (HBM4EU): Human biomonitoring guidance values (HBM-GVs) derived for bisphenol A.
Ougier E; Zeman F; Antignac JP; Rousselle C; Lange R; Kolossa-Gehring M; Apel P
Environ Int; 2021 Sep; 154():106563. PubMed ID: 33894553
[TBL] [Abstract][Full Text] [Related]
11. HBM4EU chromates study - Reflection and lessons learnt from designing and undertaking a collaborative European biomonitoring study on occupational exposure to hexavalent chromium.
Galea KS; Porras SP; Viegas S; Bocca B; Bousoumah R; Duca RC; Godderis L; Iavicoli I; Janasik B; Jones K; Knudsen LE; Leese E; Leso V; Louro H; Ndaw S; Ruggieri F; Sepai O; Scheepers PTJ; Silva MJ; Wasowicz W; Santonen T
Int J Hyg Environ Health; 2021 May; 234():113725. PubMed ID: 33714856
[TBL] [Abstract][Full Text] [Related]
12. HBM4EU combines and harmonises human biomonitoring data across the EU, building on existing capacity - The HBM4EU survey.
Gilles L; Govarts E; Rambaud L; Vogel N; Castaño A; Esteban López M; Rodriguez Martin L; Koppen G; Remy S; Vrijheid M; Montazeri P; Birks L; Sepai O; Stewart L; Fiddicke U; Loots I; Knudsen LE; Kolossa-Gehring M; Schoeters G
Int J Hyg Environ Health; 2021 Aug; 237():113809. PubMed ID: 34455198
[TBL] [Abstract][Full Text] [Related]
13. How to use human biomonitoring in chemical risk assessment: Methodological aspects, recommendations, and lessons learned from HBM4EU.
Santonen T; Mahiout S; Alvito P; Apel P; Bessems J; Bil W; Borges T; Bose-O'Reilly S; Buekers J; Cañas Portilla AI; Calvo AC; de Alba González M; Domínguez-Morueco N; López ME; Falnoga I; Gerofke A; Caballero MDCG; Horvat M; Huuskonen P; Kadikis N; Kolossa-Gehring M; Lange R; Louro H; Martins C; Meslin M; Niemann L; Díaz SP; Plichta V; Porras SP; Rousselle C; Scholten B; Silva MJ; Šlejkovec Z; Tratnik JS; Joksić AŠ; Tarazona JV; Uhl M; Van Nieuwenhuyse A; Viegas S; Vinggaard AM; Woutersen M; Schoeters G
Int J Hyg Environ Health; 2023 Apr; 249():114139. PubMed ID: 36870229
[TBL] [Abstract][Full Text] [Related]
14. Coordination of chemical analyses under the European Human Biomonitoring Initiative (HBM4EU): Concepts, procedures and lessons learnt.
Vorkamp K; Esteban López M; Gilles L; Göen T; Govarts E; Hajeb P; Katsonouri A; Knudsen LE; Kolossa-Gehring M; Lindh C; Nübler S; Pedraza-Díaz S; Santonen T; Castaño A
Int J Hyg Environ Health; 2023 Jun; 251():114183. PubMed ID: 37148759
[TBL] [Abstract][Full Text] [Related]
15. The European Human Biomonitoring Initiative (HBM4EU): Human biomonitoring guidance values for selected phthalates and a substitute plasticizer.
Lange R; Apel P; Rousselle C; Charles S; Sissoko F; Kolossa-Gehring M; Ougier E
Int J Hyg Environ Health; 2021 May; 234():113722. PubMed ID: 33711757
[TBL] [Abstract][Full Text] [Related]
16. [Human Biomonitoring for Europe (HBM4EU)-first insights into the results of the initiative].
Weise P; Apel P; Kolossa-Gehring M
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2022 Sep; 65(9):936-939. PubMed ID: 35997778
[TBL] [Abstract][Full Text] [Related]
17. Human biomonitoring guidance values (HBM-GVs) for priority substances under the HBM4EU initiative - New values derivation for deltamethrin and cyfluthrin and overall results.
Apel P; Lamkarkach F; Lange R; Sissoko F; David M; Rousselle C; Schoeters G; Kolossa-Gehring M
Int J Hyg Environ Health; 2023 Mar; 248():114097. PubMed ID: 36577283
[TBL] [Abstract][Full Text] [Related]
18. A Phased Approach for preparation and organization of human biomonitoring studies.
Fiddicke U; Pack LK; Tolonen H; Sepai O; López ME; Castaño A; Schoeters G; Kolossa-Gehring M
Int J Hyg Environ Health; 2021 Mar; 232():113684. PubMed ID: 33373963
[TBL] [Abstract][Full Text] [Related]
19. A systematic approach for designing a HBM pilot study for Europe.
Becker K; Seiwert M; Casteleyn L; Joas R; Joas A; Biot P; Aerts D; Castaño A; Esteban M; Angerer J; Koch HM; Schoeters G; Den Hond E; Sepai O; Exley K; Knudsen LE; Horvat M; Bloemen L; Kolossa-Gehring M;
Int J Hyg Environ Health; 2014 Mar; 217(2-3):312-22. PubMed ID: 23928002
[TBL] [Abstract][Full Text] [Related]
20. Development of Policy Relevant Human Biomonitoring Indicators for Chemical Exposure in the European Population.
Buekers J; David M; Koppen G; Bessems J; Scheringer M; Lebret E; Sarigiannis D; Kolossa-Gehring M; Berglund M; Schoeters G; Trier X
Int J Environ Res Public Health; 2018 Sep; 15(10):. PubMed ID: 30248963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
